Clinical trial
A Study of the Effectiveness and Safety of Topiramate in the Treatment of…
NCT00240721 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00240721 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder |
| Official title | A Randomized, Double-Blind, Multicenter, Placebo-Controlled 12-Week Study Of The Safety And Efficacy Of Two Doses Of Topiramate For The Treatment Of Acute Manic Or Mixed Episodes In Subjects With Bipolar I Disorder With An Optional Open-Label Extension |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorders, Mood Disorders, Affective Disorders, Psychotic |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 363 |
| Start date | Oct 1, 2000 |
| Completion | Sep 1, 2002 |
| First posted | Oct 18, 2005 |
| Last update posted | Jun 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: